Categories AlphaGraphs, Health Care

Key highlights from Biogen’s (BIIB) Q1 2022 earnings results

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today.

Total revenue decreased 6% year-over-year to $2.53 billion.

GAAP net income attributable to Biogen Inc. was $304 million, or $2.06 per share, compared to $410 million, or $2.69 per share, last year. Adjusted EPS amounted to $3.62.

For full-year 2022, total revenue is estimated to be $9.7-10 billion while adjusted EPS is expected to be $14.25-16.00.

Prior performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Beyond short-term challenges, Cisco’s (CSCO) prospects remain intact

Cisco Systems Inc. (NASDAQ: CSCO) is the undisputed leader in networking technology, but its core business has been facing challenges over the past few years. While the company faces stiff

Earnings: Applied Materials (AMAT) Q2 profit, revenue increase

Semiconductor technology company Applied Materials, Inc. (NASDAQ: AMAT) on Thursday reported higher earnings and revenues for the second quarter of 2022. However, the results missed analysts' estimates. Adjusted net income

Target (TGT) expects Q1 headwinds to continue to impact profitability in the near term

Shares of Target Corporation (NYSE: TGT) were down 4% on Thursday, yet to fully recover from the beating it took a day earlier after delivering mixed results for the first

Add Comment
Viewing Highlight